Proteomic and Membrane Lipid Correlates of Reduced Host Defense Peptide. by Kohler, Christian et al.
UCLA
UCLA Previously Published Works
Title
Proteomic and Membrane Lipid Correlates of Reduced Host Defense Peptide.
Permalink
https://escholarship.org/uc/item/9wj220mq
Journal
Antibiotics (Basel, Switzerland), 8(4)
ISSN
2079-6382
Authors
Kohler, Christian
Proctor, Richard A
Bayer, Arnold S
et al.
Publication Date
2019-09-28
DOI
10.3390/antibiotics8040169
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
antibiotics
Article
Proteomic and Membrane Lipid Correlates of
Re-duced Host Defense Peptide Susceptibility in
a snoD Mutant of Staphylococcus aureus
Christian Kohler 1,†, Richard A. Proctor 2,†, Arnold S. Bayer 3,4 , Michael R. Yeaman 3,4,5,
Michael Lalk 6, Susanne Engelmann 1,7,8 and Nagendra N. Mishra 3,4,*
1 Universität Greifswald, Institut für Mikrobiologie und Molekularbiologie,17487 Greifswald, Germany;
chritian.kohler@med.uni-greifswald.de (C.K.); susanne.engelmann@helmholtz-hzi.de (S.E.)
2 University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA; rap@wisc.edu
3 Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, CA 90502, USA; abayer@labiomed.org (A.S.B); mryeaman@ucla.edu (M.R.Y.)
4 David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
5 Division of Molecular Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center,
Torrance, CA 90502, USA
6 University Greifswald, Institute of Biochemistry, 17487 Greifswald, Germany; lalk@uni-greifswald.de
7 Institute for Microbiology, Technical University Braunschweig, Institute for Microbiology, 38106
Braunschweig, Germany
8 Helmholtz Center for Infectious Research, Microbial Proteomics, 38124 Braunschweig, Germany
* Correspondence: nnmishra@ucla.edu or nmishra@labiomed.org; Tel.: +310-222-4013; Fax: +310-803-5620
† Contributed equally to the design of the study.
Received: 13 August 2019; Accepted: 24 September 2019; Published: 28 September 2019


Abstract: We previously described a transposon mutant in Staphylococcus aureus strain SH1000 that
exhibited reduced susceptibility to cationic thrombin-induced platelet microbicidal proteins (tPMPs).
The transposon insertion site was mapped to the gene snoD, the staphylococcal nuo orthologue. Hence,
further studies have been performed to understand how this mutation impacts susceptibility to tPMP,
by comparing proteomics profiling and membrane lipid analyses of the parent vs. mutant strains.
Surprisingly, the mutant showed differential regulation of only a single protein when cultivated
aerobically (FadB), and only a small number of proteins under anaerobic growth conditions (AdhE,
DapE, Ddh, Ald1, IlvA1, AgrA, Rot, SA2366, and SA2367). Corresponding to FadB impact on lipid
remodeling, membrane fatty acid analyses showed that the snoD mutant contained more short chain
anteiso-, but fewer short chain iso-branched chain fatty acids under both aerobic and anaerobic
conditions vs. the parental strain. Based upon these proteomic and membrane compositional data,
a hypothetical “network” model was developed to explain the impact of the snoD mutation upon
tPMP susceptibility.
Keywords: S. aureus; snoD mutant; lipids; proteomics; tPMP resistance
1. Introduction
Thrombin-induced platelet microbicidal proteins (tPMPs) represent an important component of
innate immunity against endovascular infections, including those caused by both methicillin-susceptible
and methicillin-resistant Staphylococcus aureus (MSSA; MRSA, respectively) [1]. For example, clinical
S. aureus strains which exhibit reduced killing by low concentrations of tPMPs in vitro are associated
with: i) endocarditis and vascular catheter-associated staphylococcemias (as compared to isolates from
soft-tissue infections) [2]; ii) more prolonged bacteremia in patients with or without endocarditis [2,3];
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and iii) increased persistence and/or reduced responsiveness to antibiotic treatment in humans [2] or
experimental endocarditis [4–6]. Reduced susceptibility to tPMPs in vitro has also been correlated
to a broad array of specific staphylococcal adaptive phenotypes: i) decreased membrane potential
(∆ψ) associated with interruption of either aerobic or anaerobic electron transport systems [7,8];
ii) increased surface positive charge due to enhanced lysinylation of phosphatidyl-glycerol (PG) and/or
D-alanylation of wall teichoic acids [8]; iii) altered membrane order (i.e., extremes of fluidity or
rigidity) [8–10]; iv) distinct changes in carotenoid content [9]; and v) alterations of the QacA membrane
transporter [11].
Previously, we found that a transposon-induced mutant in the well-characterized MSSA strain,
SH1000, was resistant to killing by low concentrations of tPMPs in vitro [4]. The transposon insert was
mapped to a locus we termed snoD, for Staphylococcal nuo orthologue [12]. Phenotypically, in addition
to reduced susceptibility to tPMPs, the mutation in snoD was associated with a reduced capacity to
maintain ∆ψ over a standard growth cycle, as well as enhanced membrane fluidity [12].
Beyond snoD, previous attempts to delineate how specific genetic regulatory mechanism(s) and/or
pathway(s) may be related to tPMP resistance have met with challenges. For example, our initial
comparative gene expression profiles by microarray were not particularly revealing (unpublished),
and suffered from several key limitations, especially: i) single growth phase time-point queries; and ii)
aerobic growth conditions, given that the snoD operon might be most important in terms of anaerobic
oxidative activities [12]. Therefore, to gain further insights into potential mechanism(s) behind the
above phenotypes observed in the snoD mutant, we compared the proteomic and membrane fatty acid
compositional profiles of this mutant with that of its isogenic parental strain, under aerobic as well as
anaerobic conditions.
2. Methods
2.1. Bacterial Strains and Growth Conditions
The study strain-pair has been described in detail before [12]. In brief, MSSA parental strain,
SH1000, and its isogenic snoD mutant were used in the present study. The snoD locus was insertionally
inactivated by transposon mutagenesis [12], and the mutant designated as SH1000-98. Staphylococcal
snoD, (like mrpD of Bacillus subtilis), is found in a seven-gene operon [13]. These genes encode
homologous proteins, and the overall architecture of at least two operons is indistinguishable [13].
snoD encodes the unique gene product which is affected by the transposon mutation only [12]. The
sno (mnh) operon was reported as Na+/H+ antiporter function before [14]. As previously published,
the SH-1000 parental strain is more susceptible to killing by sub-physiologic concentrations of tPMPs
in vitro as compared to the snoD mutant, SH1000-98 (21 ± 10% vs. 59 ± 2% survival after two
hours exposure to 2 µg/mL tPMPs bioequivalent units, respectively; p < 0.05) [4]. This platelet
peptide preparation has been previously shown to contain a mixture of tPMPs, wherein tPMP-1 is
of quantitative predominance. In addition, the snoD mutant differs from the parental strain in the
following parameters: i) cross-resistant to the membrane-active cationic peptide, protamine; and ii)
enhanced membrane fluidity.
The bioactivity of the tPMP preparations was performed as described previously [15]. For protein
preparation and lipid membrane analyses, 100 mL tryptic soy broth (TSB) (Oxoid, Wesel, Germany)
was inoculated with exponentially growing cells of an overnight culture to an initial optical density
at 540 nm (OD540) of 0.05. Cells were cultivated under vigorous agitation at 37 ◦C in baffled 500 mL
Erlenmeyer flasks to an OD540 of 0.7. Afterwards, 50 mL of the culture were shifted to anaerobic
conditions by cultivating in 50 mL Falcon Tubes under gentle agitation at 37 ◦C. Anaerobic conditions
were verified by using the redox indicator, resazurin, as previously described [16].
Antibiotics 2019, 8, 169 3 of 10
2.2. Proteomic Analyses
Cytoplasmic proteins of the parental strain and its isogenic snoD mutant were prepared in parallel
from aerobically and anaerobically grown cells. Cells were harvested by centrifugation (4 ◦C, 10 min at
7000× g), and the resulting cell pellet was washed twice with ice-cold Tris-EDTA buffer. For cell lysis,
cells were suspended in 1 mL (10 mM Tris, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, pH 7.5)
and placed in screw-cap microtubes (Sarstedt, Germany) containing 500 µL of glass beads (diameter
0.10 to 0.11, Sartorius, Goettingen, Germany). Cells were mechanically disrupted as described [17].
The lysate was centrifuged twice at 21,000× g (4 ◦C) for 25 and 45 min, respectively. The protein
concentration of the supernatant was determined using Roti-Nanoquant (Roth, Karlsruhe, Germany)
and protein solutions were stored at −20 ◦C until analyzed. To resolve the cytoplasmic proteins,
2-dimensional polyacrylamide gel electrophoresis (2D PAGE) was performed as described [17,18].
The proteins separated by 2D PAGE were stained with colloidal Coomassie brilliant blue [19] and
the gels were scanned with a light scanner with an integrated transparency unit (Quatographic,
Braunschweig, Germany). The 2D gels were then analyzed with the software Delta2D (Decodon
GmbH, Greifswald, Germany). To adjust for differences in the amount of cytoplasmic proteins detected
on 2D gels of the parental vs. the mutant strain under aerobic, as well as anaerobic conditions, data
sets obtained from three separate and independent replicates were used.
For identification of differentially expressed proteins, the respective spots were cut from the gels
and digested with trypsin. The resulting peptides were analyzed by matrix-assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF MS) as described [20,21] with several
modifications detailed elsewhere [17]. The combined mass spectroscopy (MS) and MS/MS peak identity
results were searched against the S. aureus 8325 protein data base with the Mascot search engine
version 2.1.0.4. (Matrix Science; London, United Kingdom) using query parameters as published by
Kohler et al. [17] where protein concentrations were considered different at p < 0.05.
2.3. Fatty Acid Extraction and Gas Chromatographic Analysis of Fatty Acid Methyl Esters (GC-FAME)
To determine the membrane fatty acid composition, colonies of SH1000 and SH1000-98 were
freshly sub-cultured from original plates and grown on sheep blood agar in a quadrant pattern at 35 ◦C,
in parallel aerobically and anaerobically (in BBL Gaspacks, producing an atmosphere of more than
15% CO2). A second subculture was streaked in order to fully acclimate the strains to these respective
growth conditions. Approximately 20 mg of cell mass were then harvested after 24 hours from the
late exponential phase of growth (3Q) and placed into 13 × 100 mm test tubes. Next, the cells were
saponified, methylated, and fatty acid esters were extracted into hexane as described [9]. The resulting
methyl ester mixtures were separated by an Agilent 5890 dual-tower gas chromatograph. Specifically,
fatty acids were identified by a well-characterized microbial identification system, utilizing individual
known fatty acids as positive controls (Sherlock 4.5; MIDI Inc.; Wilmington, DE). For statistical analysis,
data were analyzed by the unpaired, two-tailed Student’s t test, with p < 0.05 representing a significant
difference. A minimum of two independent runs were performed on different days.
2.4. Pathway Analysis and Bioinformatics
Gene functions were imputed based on known genomic relationships available through the
University of Nebraska Transposon Mutant Library (formerly, NARSA) [22]. Pathway analysis and
interpretive results were derived in part using information obtained from the Kegg database [23].
3. Results
3.1. Proteomics Analyses
Under aerobic conditions, changes in the proteome of the snoD mutant were surprisingly quite
limited (Table 1). Only SA0224 (similar to FadB = 3-hydroxyacyl-CoA dehydrogenase) was increased in
the snoD mutant. This enzyme is involved in the β-oxidation of fatty acids, as well as in the propanoate
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and butanoate pathways. In contrast, under anaerobic conditions, more significant changes in the
proteome of the snoD mutant were observed. For example, the mutant showed increased Ddh, a lactic
acid dehydrogenase, and Ald1, an amino acid dehydratase. Both of these enzymes oxidize NADH as
they perform their enzymatic roles. Additionally, IlvA1, an enzyme involved in deamination of amino
acids, was also increased. This enzyme intersects pathways involved in the formation of branched
chain fatty acids. Moreover, DapE, which metabolizes lysine to N-succinyl-LL-2,6-diaminopimelate,
was decreased in the snoD mutant relative to its parental counterpart under anaerobic conditions.
The reduction in DapE would be expected to increase the pool of lysine available for lysinylation of the
cell membrane, thereby increasing the relative positive charge of the cell surface. Earlier publications
suggested that snoD might be in an operon concerned primarily with osmoprotection, and that the
snoD mutant was less halotolerant than its parental strain [12]. Therefore, proteomic analyses were
performed aerobically and anaerobically, in parallel, after growth of the strains under several salt
concentrations (range of NaCl concentrations = 1 M, 2 M, 2.5 M, and 3 M). No significant differences
in proteome profiles, aerobically or anaerobically, were found in the snoD vs. parental strains when
challenged across this range of high salt concentrations (data not shown).
Table 1. Proteins of which the amount was affected by snoD mutation under anaerobic conditions.
Protein (Annotation From 315) Function Ratio log2 (SH1000/snoD)
Increased in parent
AdhE (SA0143) Acetaldehyde DH 1.46
(SA2367) Theoretical protein 1.044
Decreased in mutant
DapE (SA1814) Lysine metabolism 1.021
(SA2366) Theoretical protein 1.051
AgrA (SA1844) Virulence regulator 1.287
Increased in mutant
IlvA1 (SA1271) Threonine/serine dehydrase −4.17
Ald1 (SA1272) α-amino acid dehydrogenase −1.667
Ddh (SA2312) D-lactate dehydrogenase −1.006
3.2. Fatty Acid Analyses
Bacterial growth entails a substantial portion of the acyl chains of lipids in membrane to maintain
the optimum level of fluidity/rigidity [9,10,24]. Previous studies have shown that changes in the fatty
acid composition of S. aureus can correlate with in vitro resistance to cationic host defense peptides,
including tPMPs [9,10]. Hence, we examined fatty acid compositions of the parent and snoD mutant
strains under both aerobic and anaerobic conditions. Among fatty acid species prevalent in S. aureus,
large changes in membrane fluidity begin to occur at C17, and are even more pronounced at C15 and
C13; hence, these species were grouped in this manner for our analyses. As can be seen in Table 2,
both parental and mutant strains showed major fatty acid content differences anaerobically, with
significantly decreased anteiso-branched chain, unsaturated-, and polyunsaturated-fatty acids. Also,
the amount of short iso-branched fatty acids increased, while long iso-branched fatty acids decreased
with a shift to anaerobic conditions. The snoD mutant contained more short chain anteiso-branched
fatty acids and fewer short chain iso-branched fatty acids under both growth conditions as compared
to the parental strain. In contrast, unsaturated fatty acid profiles were increased to an equivalent extent
in both of the strains under anaerobic conditions (full fatty acid analysis shown as Table 3).
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Table 2. Summary fatty acid compositional differences between parent and snoD mutant.
Fatty Acid
Species
SH1000-98 * p value SH1000-WT * p value
Aerobic Anaerobic Aerobic Anaerobic
Anteiso
(C13–17) 64.49 ± 0.11 39.07 ± 0.49 0.006 61.16 ± 1.16 35.85 ± 1.10 0.002
Unsaturated
Polyunsaturated
subset (C20)
3.58 ± 0.14
0.42 ± 0.01
12.81 ± 0.16
0.49 ± 0.01
0.0003
0.045
3.565 ± 0.40
0.315 ± 0.01
12.10 ± 0.09
0.42 ± 0.01
0.016
0.027
Short Isos
(C13–15) 5.97 ± 0.08 14.69 ± 0.25 0.007 6.895 ± 0.13 16.60 ± 0.41 0.015
Long Isos
(C16–20) 6.03 ± 0.05 5.205 ± 0.05 0.003 7.195 ± 0.08 5.30 ± 0.03 0.009
* p-value = aerobic vs. anaerobic.
Table 3. Complete fatty acid analysis of strain-pair under aerobic and anaerobic conditions.
Fatty Acid
Species
Aerobic Anaerobic
SH1000-WT SH1000-98 p-value * SH1000-WT SH1000-98 p-value **
13:0 iso - 0.325 ± 0.01 0.265 ± 0.02
13:0 anteiso - 0.105 ± 0.01 - -
14:0 iso 1.18 ± 0.03 0.78 ± 0.01 0.01 1.985 ± 0.02 1.455 ± 0.04 0.007
14:0 0.215 ± 0.02 0.195 ± 0.01 1.07 ± 0.08 0.765 ± 0.011
15:1 iso G 0.165 ± 0.01 0.15 ± 0.00 0.325 ± 0.02 -
15:0 iso 5.75 ± 0.11 5.185 ± 0.06 14.29 ± 0.42 12.97 ± 0.20
15:0anteiso 43.96 ± 0.72 46.15 ± 0.04 31.025 ± 0.93 33.495 ± 0.40
15:0 - - 0.795 ± 0.05 0.31 ± 0.01 0.03
16:0 iso 3.05 ± 0.09 1.965 ± 0.06 0.009 1.17 ± 0.01 1.11 ± 0.01
16:0 1.75 ± 0.10 1.81 ± 0.00 3.94 ± 0.16 3.98 ± 0.06
15:0 2OH - - 0.23 ± 0.01 0.205 ± 0.01
17:0 iso 3.93 ± 0.07 3.55 ± 0.06 3.835 ± 0.01 3.695 ± 0.05
17:0 anteiso 17.2 ± 0.44 18.24 ± 0.16 4.82 ± 0.17 5.57 ± 0.08 0.06
17:0 0.215 ± 0.04 0.2 ± 0.01 2.075 ± 0.011 0.96 ± 0.04 0.02
18:0 iso 1.555 ± 0.01 1.02 ± 0.01 0.0025 0.395 ± 0.04 0.375 ± 0.04
18:1w9c 2.775 ± 0.04 3 ± 0.13 5.91 ± 0.03 6.13 ± 0.08
18:1w7C 0.525 ± 0.01 0.58 ± 0.01 1.35 ± 0.03 1.515 ± 0.04
18:0 6.75±0.014 6.93 ± 0.08 10.4 ± 0.17 10.58 ± 0.00
19:0 iso 1.335±0.01 1.185 ± 0.01 1.07 ± 0.01 1.135 ± 0.04
19:0 anteiso 3.61 ± 0.04 3.68 ± 0.03 0.97 ± 0.04 1.225 ± 0.02 0.04
19:0 0.245±0.04 0.235 ± 0.01 2.25 ± 0.18 1.145 ± 0.06
20:4
w6,9,12,15c
0.315± 0.01 0.415 ± 0.01 0.005 0.42 ± 0.01 0.49 ± 0.01 0.04
20:1 w9c 2.49 - 4.835 ± 0.04 5.165 ± 0.04
20:0 2.5 ± 0.056 2.615 ± 0.063 3.495 ± 0.08 4.055 ± 0.06 0.02
20:0 iso 0.375 ± 0.01 0.31 ± 0.014 - -
* p-value = comparison between aerobic condition; ** p-value = comparison between anaerobic condition.
4. Discussion
The scope of significant proteomic changes in the snoD mutant strain was surprisingly limited,
especially under aerobic conditions. In particular, only locus SA0224 (similar to FadB = 3-hydroxyacyl-CoA
dehydrogenase) was differentially upregulated in the snoD mutant under aerobic conditions. FadB
shortens fatty acid chains, which would be consistent with the previously documented increases
in membrane fluidity in our snoD mutant [12]. In turn, this observation is consistent with prior
linkage of increased membrane fluidity phenotypes with increased resistance of S. aureus to tPMPs
in vitro [1,7–10,25]. Increased membrane fluidity is associated with proton leak and reduced membrane
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potential [12] with increased tPMP resistance, as shown in the model (Figure 1). As illustrated,
β-oxidation of fatty acids by FadB yields NADH, which must then be oxidized for metabolism to
continue, as a large number of dehydrogenases require this substrate as a co-factor. Because the
cytochrome oxidase system would be fully functional aerobically, the products of central metabolism
that generate NADH could be efficiently processed under aerobic conditions by cytochrome oxidase.
Importantly, Sharma-Kuinkel et al. previously demonstrated that the Fad operon correlates with clonal
complex type 30 (CC30) and may confer upon S. aureus the ability to adapt for survival in the face
of cationic agents such as daptomycin [26]. In turn, the Fad operon may give staphylococcal strains
virulence advantages in persistent or other human infections.
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dehydrogenase [28]. We found Ddh to be significantly upregulated in the snoD mutant under anaerobic
conditions. Likewise, the Ald1 protein is over-represented anaerobically in the snoD mutant proteome
as compared to its isogenic parental strain. Importantly, we previously reported that Ald1 expression
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aerobically was increased in the tPMP-resistant hemB and menD small colony variants, both of which
have defects in oxidizing NADH [15,29].
As a unifying model, we have related the observed changes in Ddh and Ald1 profiles in the snoD
mutant to the relative redox state, wherein pathways optimized to oxidize NADH anaerobically are
likely operative (Figure 1). The relatively greater increase in AdhE in the parent probably relates to the
fact that this protein may already be adequately expressed in the mutant, but needs to be induced in
the parent to accomplish anaerobic oxidation of NADH.
In addition to changes in NADH/NAD+ cycling in the snoD mutant, we identified protein
perturbations that should facilitate changes in cell membrane lipid composition. In S. aureus, the IlvA1
protein acts as a threonine desaturase, which catalyzes the anaerobic formation of 2-oxobutanoate
(α-ketobutyrate) and ammonia from threonine in a two-step reaction (Figure 1). IlvA1 shuttles amino
acids towards (S)-2-methylbutanoyl-CoA, which would be expected to increase both the proportion
of C15 and C17 anteiso-branched fatty acids and, consequently, the membrane fluidity. The ratio
of anteiso- to short iso-branch chain lipids is approximately 2.6 in the snoD mutant, as compared to
2.1 in the parent. This shift in the lipid profile of the snoD mutant strain is similar to the membrane
perturbations in B. subtilis during “cold adaptation” under anaerobic conditions [24], a modification that
also increases membrane fluidity [30]. Anteiso-branched fatty acids produce more fluid membranes as
compared to iso-branched chain fatty acids [31]); hence, the present results support the previously
identified changes in membrane fluidity in the snoD mutant [10]. The “breakpoint” for changes in
membrane fluidity occurs in iso-branched chain fatty acids at C15-to-C16 species. Thus, we used
this breakpoint to group our data for relevant analyses. While the amount of anteiso-branched fatty
acids is normally lower anaerobically (which would hypothetically render cell membranes more rigid),
the anteiso-branched fatty acids in the snoD mutant are maintained at relatively higher levels, thereby
allowing for greater fluidity than the parent. All of the changes in fatty acid length and branching
favor increased membrane fluidity.
In theory, increased membrane fluidity may impact susceptibility to tPMPs and other cationic
host defense peptides in at least two ways. First, the insertion capacity of these cationic peptides into
target membranes is likely to be physically altered by such extremes of membrane order [1,7–10,25,32].
Second, a more fluid membrane allows for greater transmembrane leakage of protons, dissipating the
∆ψ [33], a phenotype that is critically involved in tPMP activity [7]. In direct support of this notion,
the mutation in snoD is associated with a substantial decrease in ∆ψ [12]. One possible explanation
for this observation is that increased fluidity would allow fewer tPMP molecules to insert into the
cell membrane of the snoD mutant, limiting their membrane perturbing actions. This defect would
also blunt their eventual penetration into the cytoplasmic compartment of the snoD mutant where
these peptides are believed to exert multiple antimicrobial mechanisms [9–12,34]. Finally, reduced
DapE content in the snoD mutant would decrease lysine breakdown (Figure 1). This would increase
lysine availability for lysinylating phosphatidylglycerol (PG) and synthesizing this positively-charged
membrane species, lysyl-PG; this event, in turn, would likely increase the relative positive surface
charge in the snoD mutant, resulting in a “charge-repulsive milieu” against host cationic peptides,
like tPMPs [8].
In summary, we have previously reported that mutation and loss-of-function of the SnoD complex
in S. aureus is correlated with increased membrane fluidity and reduced ∆ψ, as well as with decreased
NADH oxidation and increased tPMP resistance. This mutant appears to foster these adaptations by
engaging alternative pathways to oxidize NADH, increase membrane fluidity, and redirect metabolism
to allow for a relative increase in surface charge. Of most importance, by modifying the expression of
only a very small group of proteins, the organism becomes more resistant to an important host defense
peptide (tPMP), supporting its survivability under stress conditions.
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